This Ovintiv Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday

Citigroup analyst Scott Gruber has downgraded Ovintiv Inc. (NYSE: OVV) from Buy to Neutral, while raising the price target from $52 to $62. Ovintiv shares closed at $62.08 on Friday. This downgrade is part of a broader trend, as several companies, including Terns Pharmaceuticals, Burford Capital, and Boston Scientific, also received downgrades from various analysts.